$1.45
0.01[0.69%]
At close: Apr 22
$1.45
0[0.00%]
PreMarket: 9:04AM EDT
Corvus Pharma
(NASDAQ:CRVS)Latest News for Corvus Pharma Stock (NASDAQ:CRVS)
Corvus Pharma Stock (NASDAQ: CRVS)
Categories: All
Tuesday, April 09, 2024
Monday, April 01, 2024
Wednesday, March 27, 2024
Wednesday, March 20, 2024
Tuesday, March 19, 2024
Monday, March 18, 2024
Monday, February 12, 2024
Friday, February 09, 2024
Thursday, February 08, 2024
Monday, December 11, 2023
- Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Dec 11, 2023, 7:59AM
- Saturday, Corvus Pharmaceuticals Announced New Interim Data From Phase 1/1B Trial Of Soquelitinib For Relapsed Peripheral T Cell Lymphoma, Demonstrating Durable Anti-tumor Activity And Overall Survival Rates Exceeding Current Standard Of Care TherapiesBenzinga Newsdesk - Dec 11, 2023, 5:07AM
Tuesday, November 07, 2023
Monday, November 06, 2023
Thursday, November 02, 2023
- Corvus Pharmaceuticals To Present New Interim Soquelitinib Data From Its Phase 1/1b T Cell Lymphoma Trial At The 65th ASH Annual Meeting & ExpositionBenzinga Newsdesk - Nov 2, 2023, 9:21AM
- Reported Earlier, Corvus Pharmaceuticals Publishes Preclinical Data Demonstrating Potential Of ITK Inhibition With Soquelitinib As A Novel Approach To T Cell-Mediated Inflammatory And Immune DiseasesBenzinga Newsdesk - Nov 2, 2023, 2:32AM
Thursday, September 07, 2023
Wednesday, September 06, 2023
Friday, August 18, 2023
Tuesday, August 08, 2023
Monday, July 10, 2023
Thursday, July 06, 2023
Friday, June 16, 2023
Thursday, June 15, 2023
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jun 15, 2023, 1:31PM
- Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Jun 15, 2023, 1:12PM
- Corvus Pharmaceuticals Says Updated Data From CPI-818 Phase 1/1B Trial In Solid & Hematological Cancers Continues To Demonstrate The Potential Of ITK Inhibition And Absolute Lymphocyte Count Biomarker In T Cell LymphomaBenzinga Newsdesk - Jun 15, 2023, 7:21AM
Tuesday, May 30, 2023
Wednesday, May 17, 2023
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - May 17, 2023, 1:31PM
- Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - May 17, 2023, 12:51PM
- Corvus Pharmaceuticals To Present New CPI-818 Data At International Conference On Malignant Lymphoma On June 13-17Benzinga Newsdesk - May 17, 2023, 9:03AM